Patents by Inventor Tae-Wook Hahn

Tae-Wook Hahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINE COMPOSITION COMPRISING PLANT-EXPRESSED RECOMBINANT ZIKA VIRUS ENVELOPE PROTEIN AND PREPARATION METHOD THEREFOR
    Publication number: 20230293665
    Abstract: The present invention relates to a vaccine composition including, as active ingredients, a recombinant Zika virus envelope protein including an amino acid sequence of SEQ ID NO: 1, and an adjuvant selected from alum, monophosphoryl lipid A (MPL), or a combination thereof, a recombinant vector for producing the recombinant Zika virus envelope protein in a plant, a transformant transformed with the vector, and a method for producing the recombinant Zika virus envelope protein.
    Type: Application
    Filed: August 11, 2021
    Publication date: September 21, 2023
    Inventors: Tae-Wook Hahn, Minna Shin, Eun-Ju Sohn, Hyangju Kang
  • Vaccine composition comprising recombinant protein for preventing swine infection
    Patent number: 10519199
    Abstract: Provided are a recombinant protein for producing a swine Mycoplasma infection-preventing vaccine composition, and a swine Mycoplasma hyopneumoniae and Mycoplasma hyorhinis infection-preventing vaccine composition including the recombinant protein. When the recombinant proteins for the vaccine production in accordance with the present disclosure are added to the swine Mycoplasma infection-preventing vaccine composition, the immune response to the swine Mycoplasma hyopneumoniae and swine Mycoplasma hyorhinis strain and the immune response to the P97 protein are increased. As a result, the present vaccine exhibits a defensive effect superior to an existing commercially available vaccine.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: December 31, 2019
    Assignee: INNOVAC
    Inventors: Tae Wook Hahn, Kashinath Abhijit Barate, Ki Ju Kim, Woo Sung Shin
  • Vaccine Composition Comprising Recombinant Protein for Preventing Swine Mycoplasma Infection
    Publication number: 20190177375
    Abstract: Provided are a recombinant protein for producing a swine Mycoplasma infection-preventing vaccine composition, and a swine Mycoplasma hyopneumoniae and Mycoplasma hyorhinis infection-preventing vaccine composition including the recombinant protein. When the recombinant proteins for the vaccine production in accordance with the present disclosure are added to the swine Mycoplasma infection-preventing vaccine composition, the immune response to the swine Mycoplasma hyopneumoniae and swine Mycoplasma hyorhinis strain and the immune response to the P97 protein are increased. As a result, the present vaccine exhibits a defensive effect superior to an existing commercially available vaccine.
    Type: Application
    Filed: August 14, 2017
    Publication date: June 13, 2019
    Inventors: Tae Wook Hahn, Kashinath Abhijit Barate, Ki Ju Kim, Woo Sung Shin
  • Adenovirus type7 vectors
    Publication number: 20040253210
    Abstract: The current invention provides novel adenovirus type 7 cosmid vectors for the production of adenovirus type 7 for use in gene transfer. In particular, the invention provides a replication-defective adenovirus type 7 that expresses one or more HIV polypeptides for use in stimulating an immune response to HIV-1.
    Type: Application
    Filed: August 5, 2004
    Publication date: December 16, 2004
    Inventors: Marjorie Robert-Guroff, Xinli Nan, Bo Peng, Tae-Wook Hahn